Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology).

MLA

Scoccianti, Silvia, et al. “Radiotherapy and Temozolomide in Anaplastic Astrocytoma: A Retrospective Multicenter Study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology).” Neuro-Oncology, vol. 14, no. 6, June 2012, pp. 798–807. EBSCOhost, https://doi.org/10.1093/neuonc/nos081.

APA

Scoccianti, S., Magrini, S. M., Ricardi, U., Detti, B., Krengli, M., Parisi, S., Bertoni, F., Sotti, G., Cipressi, S., Tombolini, V., Dall’oglio, S., Lioce, M., Saieva, C., Buglione, M., Mantovani, C., Rubino, G., Muto, P., Fusco, V., Fariselli, L., … Biti, G. (2012). Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology). Neuro-Oncology, 14(6), 798–807. https://doi.org/10.1093/neuonc/nos081

Chicago

Scoccianti, Silvia, Stefano Maria Magrini, Umberto Ricardi, Beatrice Detti, Marco Krengli, Salvatore Parisi, Filippo Bertoni, et al. 2012. “Radiotherapy and Temozolomide in Anaplastic Astrocytoma: A Retrospective Multicenter Study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology).” Neuro-Oncology 14 (6): 798–807. doi:10.1093/neuonc/nos081.